Technical Advisory Group on Tuberculosis for the WHO European Region: report of the Fifteenth Meeting 18−20 May 2021. Virtual meeting hosted out of Copenhagen, Denmark
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
World Health Organization. Regional Office for Europe
Abstract
Description
10 p.
The Fifteenth Meeting of the European Technical Advisory Group on Tuberculosis Control (TAG-TB) was held on 18–20 May 2020. Due to the COVID-19 pandemic, the Meeting was held virtually, allowing all participants to participate remotely. The objectives of the Meeting were to: 1) review and discuss the progress made in implementing the recommendations of the 14th Meeting of the Technical Advisory Group on Tuberculosis (TAG-TB); 2) discuss prioritized actions and interventions, which the WHO Regional Office for Europe will embark upon and/or accelerate its support to Member States for in response to tuberculosis (TB), drug-resistant TB (DR-TB) and TB/HIV coinfection during the COVID-19 pandemic; 3) review and advise on plans for the development of a Roadmap on tuberculosis for the WHO European Region for 2023–2030 to reach the targets set out in the End TB Strategy.
The Fifteenth Meeting of the European Technical Advisory Group on Tuberculosis Control (TAG-TB) was held on 18–20 May 2020. Due to the COVID-19 pandemic, the Meeting was held virtually, allowing all participants to participate remotely. The objectives of the Meeting were to: 1) review and discuss the progress made in implementing the recommendations of the 14th Meeting of the Technical Advisory Group on Tuberculosis (TAG-TB); 2) discuss prioritized actions and interventions, which the WHO Regional Office for Europe will embark upon and/or accelerate its support to Member States for in response to tuberculosis (TB), drug-resistant TB (DR-TB) and TB/HIV coinfection during the COVID-19 pandemic; 3) review and advise on plans for the development of a Roadmap on tuberculosis for the WHO European Region for 2023–2030 to reach the targets set out in the End TB Strategy.